Pick up almost any “thyroid support” supplement and turn it around. Odds are you’ll find a long, impressive-looking list — fifteen, twenty ingredients — often hidden inside a “proprietary blend.” The logic is clear: more looks like more. The more ingredients, the more impressive the bottle.
We made the opposite choice. Here’s why.
The problem with a long list of token doses
When you spread a supplement’s capacity across twenty ingredients, something has to give: the dose of each individual ingredient. And dose matters. The clinical evidence for selenium reducing thyroid antibodies used 200 mcg (Gärtner et al., 2002). The myo-inositol and selenium combination used 600 mg myo-inositol + 83 mcg selenium per dose, twice daily (Nordio & Basciani, 2017). You can’t spread those alongside twenty other ingredients and still hit the numbers that the research supports.
What “depth over breadth” means in practice
Thyrolume is built around a small number of ingredients chosen because they have the strongest, most direct evidence for the specific problems of Hashimoto’s and thyroid dysfunction:
- Myo-inositol — for TSH signaling and well-being
- L-selenomethionine — for antibody reduction and T4→T3 conversion
- Active B-vitamins (methylfolate + methylcobalamin) — for the many women with MTHFR variants and B12 depletion
- Zinc bisglycinate — for conversion and immune support
- Acetyl-L-carnitine — for cellular energy production
- NAC — for antioxidant defense of thyroid tissue
- Black pepper extract (Piperine) — to support absorption across the stack
Each ingredient is at a dose that matches or approaches the evidence. No padding. No proprietary blends. You can look up every dose on the label and cross-reference it against the research.
A long list of tiny doses is a label strategy. A short list of real doses is a formula strategy. We chose the formula.